BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

531762

UNJHAFOR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

UNJHA FORMULATIONS LTD. Share Price Update

As of the latest trading session, UNJHA FORMULATIONS LTD. share price is currently at ₹ 22.61, which is down by ₹ -1.68 from its previous closing. Today, the stock has fluctuated between ₹ 22.50 and ₹ 24.99. Over the past year, UNJHA FORMULATIONS LTD. has achieved a return of 11.87 %. In the last month alone, the return has been 6.02 %. Read More...

UNJHA FORMULATIONS LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    10.20

  • P/E Ratio (TTM)

    17.11

  • Beta

    0.29

  • Book Value / share

    7.40

  • Return on equity

    6.00%

  • EPS (TTM)

    1.42

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.22

info icon alternate text

UNJHA FORMULATIONS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 3.76
Operating Expense 3.55
Net Profit 0.22
Net Profit Margin (%) 5.85
Earnings Per Share (EPS) 0.50
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 3.78
Operating Expense 3.91
Net Profit -0.11
Net Profit Margin (%) -2.91
Earnings Per Share (EPS) -0.25
EBITDA -0.09
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 3.95
Operating Expense 3.25
Net Profit 0.70
Net Profit Margin (%) 17.72
Earnings Per Share (EPS) 1.56
EBITDA 0.72
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 4.43
Operating Expense 4.43
Net Profit -0.18
Net Profit Margin (%) -4.06
Earnings Per Share (EPS) -0.39
EBITDA 0.07
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 5.55
Operating Expense 5.15
Net Profit 0.39
Net Profit Margin (%) 7.02
Earnings Per Share (EPS) 0.87
EBITDA 0.41
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 18.50
Operating Expense 18.06
Net Profit 0.28
Net Profit Margin (%) 1.51
Earnings Per Share (EPS) 0.62
EBITDA 0.59
Effective Tax Rate (%) 37.77
Particulars MAR 2023 (Values in Cr)
Revenue 13.15
Operating Expense 12.86
Net Profit 0.28
Net Profit Margin (%) 2.12
Earnings Per Share (EPS) 0.63
EBITDA 0.47
Effective Tax Rate (%) 15.15
Particulars MAR 2022 (Values in Cr)
Revenue 14.16
Operating Expense 14.05
Net Profit 0.25
Net Profit Margin (%) 1.76
Earnings Per Share (EPS) 0.56
EBITDA 0.51
Effective Tax Rate (%) 16.66
Particulars MAR 2021 (Values in Cr)
Revenue 9.96
Operating Expense 10.07
Net Profit 0.10
Net Profit Margin (%) 1.00
Earnings Per Share (EPS) 0.23
EBITDA 0.35
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 10.60
Operating Expense 10.54
Net Profit 0.31
Net Profit Margin (%) 2.92
Earnings Per Share (EPS) 0.69
EBITDA 0.51
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 6.10
ROE % 6.00
ROCE % 10.71
Total Debt to Total Equity 0.00
EBITDA Margin 3.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.48
ROE % 6.00
ROCE % 8.35
Total Debt to Total Equity 0.00
EBITDA Margin 3.57
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.84
ROE % 5.35
ROCE % 9.20
Total Debt to Total Equity 0.00
EBITDA Margin 3.60
Particulars MAR 2021 (Values in Cr)
Book Value / Share 4.28
ROE % 2.14
ROCE % 5.78
Total Debt to Total Equity 0.00
EBITDA Margin 3.51
Particulars MAR 2020 (Values in Cr)
Book Value / Share 4.05
ROE % 6.63
ROCE % 9.20
Total Debt to Total Equity 0.00
EBITDA Margin 4.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.87
Total Assets 4.93
Total Liabilities 4.93
Total Equity 2.73
Share Outstanding 4480500
Price to Book Ratio 3.10
Return on Assets (%) 5.63
Return on Capital (%) 10.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 3.40
Total Liabilities 3.40
Total Equity 2.45
Share Outstanding 4480500
Price to Book Ratio 2.28
Return on Assets (%) 8.28
Return on Capital (%) 11.52
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 3.45
Total Liabilities 3.45
Total Equity 2.17
Share Outstanding 4480500
Price to Book Ratio 1.94
Return on Assets (%) 7.30
Return on Capital (%) 11.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 3.52
Total Liabilities 3.52
Total Equity 1.91
Share Outstanding 4480500
Price to Book Ratio 1.99
Return on Assets (%) 2.93
Return on Capital (%) 5.4
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.93
Total Assets 3.71
Total Liabilities 3.71
Total Equity 1.81
Share Outstanding 4480500
Price to Book Ratio 1.42
Return on Assets (%) 8.30
Return on Capital (%) 16.99
Particulars MAR 2024 (Values in Cr)
Net Income 0.45
Cash from Operations 1.07
Cash from Investing -0.10
Cash from Financing -0.05
Net change in Cash 0.86
Free Cash Flow 1.18
Particulars MAR 2023 (Values in Cr)
Net Income 0.32
Cash from Operations -0.21
Cash from Investing -0.09
Cash from Financing -0.05
Net change in Cash -0.41
Free Cash Flow -0.10
Particulars MAR 2022 (Values in Cr)
Net Income 0.25
Cash from Operations 0.40
Cash from Investing -0.02
Cash from Financing 0.00
Net change in Cash 0.25
Free Cash Flow 0.43
Particulars MAR 2021 (Values in Cr)
Net Income 0.10
Cash from Operations -0.53
Cash from Investing -0.06
Cash from Financing 0.00
Net change in Cash -0.76
Free Cash Flow -0.46
Particulars MAR 2020 (Values in Cr)
Net Income 0.30
Cash from Operations 0.50
Cash from Investing -0.10
Cash from Financing 0.00
Net change in Cash 0.28
Free Cash Flow 0.61
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2904.45 57.61 29.41 49203.14 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

UNJHA FORMULATIONS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
22.73 -6.46 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 24.50
  • 26 Days 23.50
  • 10 Days 24.10
  • 50 Days 24.10
  • 12 Days 23.90
  • 100 Days 25.40
  • 20 Days 23.60
  • 200 Days 25.60
24.20 PIVOT

First Support

24.10

First Resistance

24.40

Second Support

23.90

Second Resistance

24.50

Third Support

23.80

Third Resistance

24.70

RSI

53.86

ADX

31.27

MACD

0.37

Williams % R

-38.52

Commodity Channel Index (CCI)

77.67

Date

2025-04-29

Week

2907.00

Same Day

2.00

Month

1944.00

1 Year

0.29

3 Year

0.13

Over 1 Month

6.02%

down

Over 1 Year

11.87%

down

Over 3 Months

-11.44%

down

Over 3 Years

36.47%

down

Over 6 Months

-22.31%

down

Over 5 Years

30.91%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

UNJHA FORMULATIONS LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
63.07%
Promoter Holdings
36.92%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Jashodaben Shambhubhai Patel 739900.0 (16.51%) Shareholding of Promoter and Promoter Group
Krutiben Mayankkumar Patel 667251.0 (14.89%) Shareholding of Promoter and Promoter Group
Urveshkumar Shambhubhai Patel 162273.0 (3.62%) Shareholding of Promoter and Promoter Group
Neenaben Urveshkumar Patel 85000.0 (1.9%) Shareholding of Promoter and Promoter Group
Esha Mayank Patel 71560.0 (1.6%) Public Shareholding
Manish Patel 60491.0 (1.35%) Public Shareholding
Deep Mayankbhai Patel 57778.0 (1.29%) Public Shareholding
Narveer Yadav 52501.0 (1.17%) Public Shareholding
Jatinkumar Babulal Patel 47400.0 (1.06%) Public Shareholding

News

Left Arrow
Right Arrow

UNJHA FORMULATIONS LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

UNJHA FORMULATIONS LTD. Share Price

Unjha Formulations Ltd was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. It was promoted by Shambhubhai A Patel. The Company is a pioneer in Isabgol (Psyllium) Formulation. The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession.

The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc. It is one of the largest manufacturers of isabgul products in India. The company's products are classified under two divisions -- human consumption and veterinary products.

Its parent company M/S Urvesh Ltd. is 100% EOU is engaged in exporting of Isabol Husk & Isabgol Powder. The Company is a modern manufacturing plant, having GMP Certificate. It is a manufacturer of all kinds of Small Volume Ayurvedic Isabgol (Psyllium) powder and tested at their plant with their modern & well equipped physico chemical and Micro Biological quality control laboratory.

Company launched four new products viz.Bericof, Protobal-NT, Formentin Tablets and Nalizole in the year 1997-98.

The Company commenced its commercial production and was successfully expanding its customer base throughout the Country including U.P. Territory. Company also interested on development of Export Markets for Ferrous Sulphate, Albendazole Bolus and Iron Folic Tablets to supplement the present law domestic demand situation and achieved export turnover of Rs.0.98 during the year 1997-98.

The Company has made manufacturing agreement with Nicholas Piramal India Limited, Mumbai for sale of Isabgol Husk based Product 'FYBOGEL'.The company received a confirm export order worth Rs.30.00 lacs.

Parent organization Indian Private
NSE symbol [-]
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Unjha Formulations Ltd?

Answer Field

The share price of Unjha Formulations Ltd for NSE is ₹ 0.00 and for BSE is ₹ 22.73.

What is the Market Cap of Unjha Formulations Ltd?

Answer Field

The market cap of Unjha Formulations Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 10.20 Cr. as of now.

What is the 52 Week High and Low of Unjha Formulations Ltd?

Answer Field

The 52 Week High and Low of Unjha Formulations Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 39.00 and ₹ 19.99.

How to Buy Unjha Formulations Ltd share?

Answer Field

You can trade in Unjha Formulations Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Unjha Formulations Ltd?

Answer Field

The 1 year returns on the stock has been 11.87%.

What is the Current Share Price of Unjha Formulations Ltd?

Answer Field

Unjha Formulations Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 22.73 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Unjha Formulations Ltd Share?

Answer Field

The market cap of Unjha Formulations Ltd for NSE ₹ 0.0 & for BSE ₹ 10.20 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Unjha Formulations Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Unjha Formulations Ltd share is 17.11.

What is the PB ratio of Unjha Formulations Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Unjha Formulations Ltd share is 7.40.

How to Buy Unjha Formulations Ltd Share?

Answer Field

You can trade in Unjha Formulations Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Unjha Formulations Ltd Share on Bajaj Broking App?

Answer Field

To buy Unjha Formulations Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Unjha Formulations Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|